New drug combo may speed up miscarriage care
NCT ID NCT05304273
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different drug combinations to end a non-viable pregnancy in the first trimester. One group received the standard treatment (mifepristone plus misoprostol), while the other received letrozole plus misoprostol. The goal was to see which combination works faster and more completely, potentially offering a better option for women experiencing early miscarriage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MISCARRIAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Calcutta National Medical College and Hospital
Kolkata, West Bengal, 700014, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a hormone blocker make miscarriage care more complete?
- Can a simple office procedure replace surgery for early miscarriage care?
- Could low egg count predict miscarriage? new study seeks answers
- New DNA tests could spot hidden chromosome flaws in infertility and developmental disorders
- Miscarriage care showdown: camera surgery vs suction – which works better?
- Study: surgical abortion may harm sexual function more than medical abortion